Skip to content

collaborations

Hit identification in CCR2 using ultra-large virtual screening and FEP

Barcelona, Leiden and Uppsala, June 27 2024 – Pharmacelera, the leading provider of computational tools for hit discovery, the Leiden Academic Center for Drug Research (LACDR) at Leiden University and MODSIM Pharma AB, the leading provider of physics-based biomolecular simulations tools, have announce the collaboration on… Read More »Hit identification in CCR2 using ultra-large virtual screening and FEP

Modsim pharma and Pharmacelera announce a partnership on providing an extended portfolio of in-silico services

Barcelona and Uppsala, March 2nd, 2023 – Pharmacelera, the leading provider of computational tools for hit discovery, and MODSIM Pharma AB, the leading provider of physics-based biomolecular simulations tools, have announced a technology and business partnership to jointly provide an efficient in-silico platform from Hit… Read More »Modsim pharma and Pharmacelera announce a partnership on providing an extended portfolio of in-silico services